AP

Atwood & Palmer Portfolio holdings

AUM $1.6B
This Quarter Return
+21.77%
1 Year Return
+25.98%
3 Year Return
+71.23%
5 Year Return
+127.94%
10 Year Return
+264.26%
AUM
$740M
AUM Growth
+$740M
Cap. Flow
-$23.4M
Cap. Flow %
-3.16%
Top 10 Hldgs %
35.03%
Holding
338
New
16
Increased
33
Reduced
45
Closed
16

Sector Composition

1 Technology 17.85%
2 Healthcare 15.39%
3 Financials 12.79%
4 Industrials 11.9%
5 Consumer Discretionary 4.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PSX icon
251
Phillips 66
PSX
$52.8B
$12K ﹤0.01%
163
-75
-32% -$5.52K
IJH icon
252
iShares Core S&P Mid-Cap ETF
IJH
$99.4B
$12K ﹤0.01%
70
GEM icon
253
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.07B
$12K ﹤0.01%
+400
New +$12K
VGT icon
254
Vanguard Information Technology ETF
VGT
$99.1B
$11K ﹤0.01%
40
SPG icon
255
Simon Property Group
SPG
$58.7B
$11K ﹤0.01%
155
SHAK icon
256
Shake Shack
SHAK
$4.23B
$11K ﹤0.01%
200
CMG icon
257
Chipotle Mexican Grill
CMG
$56B
$11K ﹤0.01%
10
BSCP icon
258
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$3.03B
$11K ﹤0.01%
+500
New +$11K
NKLA
259
DELISTED
Nikola Corporation Common Stock
NKLA
$10K ﹤0.01%
+150
New +$10K
YUM icon
260
Yum! Brands
YUM
$40.1B
$10K ﹤0.01%
116
NOW icon
261
ServiceNow
NOW
$191B
$10K ﹤0.01%
25
PRNB
262
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$9K ﹤0.01%
+150
New +$9K
MDT icon
263
Medtronic
MDT
$118B
$9K ﹤0.01%
100
HRB icon
264
H&R Block
HRB
$6.83B
$9K ﹤0.01%
650
BA icon
265
Boeing
BA
$176B
$9K ﹤0.01%
50
ARCC icon
266
Ares Capital
ARCC
$15.7B
$9K ﹤0.01%
643
BMY.RT
267
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$8K ﹤0.01%
2,120
VNQ icon
268
Vanguard Real Estate ETF
VNQ
$34.1B
$8K ﹤0.01%
100
SPR icon
269
Spirit AeroSystems
SPR
$4.85B
$8K ﹤0.01%
350
NTRS icon
270
Northern Trust
NTRS
$24.7B
$8K ﹤0.01%
100
MMC icon
271
Marsh & McLennan
MMC
$101B
$8K ﹤0.01%
75
APA icon
272
APA Corp
APA
$8.11B
$8K ﹤0.01%
600
AAWW
273
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$7K ﹤0.01%
160
SYK icon
274
Stryker
SYK
$149B
$7K ﹤0.01%
39
NVS icon
275
Novartis
NVS
$248B
$7K ﹤0.01%
75